StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3036% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Share repurchases by Year

Share repurchases — Aggregate repurchase value under repurchase programs ($M) ($M)

Vertex Pharmaceuticals Share repurchases: $2,000M in FY2025, up 66.7% from a year earlier.

Latest, FY2025
2,000
Period ended Dec 31, 2025
Change on a year earlier
+66.7%
1,200 in FY2024
History
7 years
Since FY2018
Sources
5
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-13) ↗

Reported in Form 10-Q / 10-K Note (Common Stock & Share Repurchases).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedShare repurchases — Aggregate repurchase value under repurchase programs ($M) ($M)Year on yearSource
FY2025Dec 31, 20252,000+66.7%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 20241,200+180.6%Form 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 2023428–Form 10-K (filed 2026-02-13) ↗
FY2021Dec 31, 20211,425+164.4%Form 10-K (filed 2024-02-15) ↗
FY2020Dec 31, 2020539+189.8%Form 10-K (filed 2023-02-10) ↗
FY2019Dec 31, 2019186-46.9%Form 10-K (filed 2022-02-09) ↗
FY2018Dec 31, 2018350–Form 10-K (filed 2021-02-11) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Share repurchases ($M), annual FY2018–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/buyback-val-tot

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.